FDA — authorised 7 May 2001
- Application: BLA103948
- Marketing authorisation holder: GENZYME
- Local brand name: CAMPATH
- Indication: VIAL — INTRAVENOUS
- Status: approved
🇺🇸 Campath in United States
FDA authorised Campath on 7 May 2001
Marketing authorisations
FDA
- Status: approved
Campath in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Campath approved in United States?
Yes. FDA authorised it on 7 May 2001; FDA has authorised it.
Who is the marketing authorisation holder for Campath in United States?
GENZYME holds the US marketing authorisation.